Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.
Stewart, A Keith
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2004 - 8170-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1078-0432
10.1158/1078-0432.CCR-04-1106 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Middle Aged
Multiple Myeloma--therapy
Prednisone--administration & dosage
Stem Cell Transplantation
Survival Rate
Thalidomide--administration & dosage
Transplantation, Autologous
Treatment Outcome
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Dec 2004 - 8170-6 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
1078-0432
10.1158/1078-0432.CCR-04-1106 doi
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Middle Aged
Multiple Myeloma--therapy
Prednisone--administration & dosage
Stem Cell Transplantation
Survival Rate
Thalidomide--administration & dosage
Transplantation, Autologous
Treatment Outcome